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SUMMARY 
Mean survival time following intracerebral inoculation of dengue virus was 
reduced and the titre of the virus in the brain of immunosuppressed mice was 
markedly increased. A single dose of cyclophosphamide given 24 h after dengue 
virus i.c. or i.p. substantially reduced the number of antibody forming cells in the 
spleen. Three doses of dengue virus, each followed bycyclophosphamide 24 h later, 
produced specific hyporesponsiveness to the dengue virus but not to a heterologous 
virus (Coxsackie B4), with a reduction in antibody forming cells in the spleen of 
such animals against dengue virus but not against Coxsackie B4 virus. Adoptive 
immunity by antiserum was abolished along with increased titres of the virus in the 
brain of immunosuppressed mice but the protection could be restored by a second 
dose of antiserum. Pre-treatment of mice with immune or normal spleen cells i.v. or
reconstitution fimmunosuppressed mice by such cells had no effect. Thus, humoral 
antibodies play  crucially important role in host defence mechanism in recovery 
of mice from primary dengue virus infection. 
INTRODUCTION 
Immunosuppression hasbeen used to convert asilent abortive virus infection into a lethal 
infection, accompanied byincreased titres of the virus and an increased number of infected 
and destroyed cells in the target organs of various experimental models, namely, West Nile 
(Cole & Nathanson, I968), encephalomyocarditis (Murphy & Glasgow, ~968), Sendai 
(Robinson, Cureton & Heath, I969) and influenza (Hurd & Heath, I975) viruses. A mouse- 
adapted strain of dengue virus produces acute lethal infection in adult mice if injected by the 
intracerebral (i.c.) route but is almost innocuous when given by other outes (Thind & Price, 
1969; Tandon & Chaturvedi, 1977). Pre-treatment of mice with humoral antibody protects 
them against i.c. challenge with the dengue type 2 virus but immune splenic cells have no 
protective ffect (Chaturvedi, Tandon & Mathur, I977). Immunosuppression provides the 
means of assessing the role of immune response in recovery from primary virus infection. 
In the present study, therefore, the effect of immunosuppression by cyclophosphamide 
on the response of mice to dengue type 2 virus infection has been investigated with respect 
to active immunization and adoptive immunization by antisera or immune cells. 
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METHODS 
Mice. The study was carried out on male albino mice (Swiss strain) weighing 2o to 25 g 
(4 to 6 months old). 
Cyclophosphamide. The cyclophosphamide (CY) used was Endoxan-ASTA (Khandelwal 
Lab. Pvt. Ltd, ASTA Werke, A-G, West Germany). The dose of CY was 25o mg/kg body 
weight and was given by the intraperitoneal (i.p.) route. 
Virus. Dengue type 2 (DV) virus (strain 23o85), passed in the brain of mice, was originally 
obtained from the Virus Research Centre, Poona. The strain produced IOO% mortality 
after intracerebral (i.c.) inoculation in infant and adult mice. The virus was used in the form 
of infected mouse brain suspension in doses of about IOO LDs0. The titres of virus were 
determined by i.c. inoculation in adult mice and the LDso was calculated by the method of 
Reed & Muench (r938). Coxsackie B4 virus was obtained from the Haffkine Institute, 
Bombay and had undergone I2 passages in monkey kidney tissue culture (MKTC). The 
virus pool was prepared and the titre determined in MKTC. 
Effect of CY on i.c. inoculation of DV. The effect of CY on the mortality pattern in mice 
was studied by giving the drug one day before, the same day and i, 2, 3, 4, 5 or 6 days after 
i.c. DV inoculation. The mice were examined up to 21 days for illness and mortality. From 
the set of mice given CY at I day after DV, two mice were killed daily and the titre of virus 
was estimated in the brain tissue. For control, titres were determined aily in an equal 
number of mice given virus alone. 
Effect of CY on i.p. inoculation ofDV. CY was given one day before, the same day and 
one day after i.p. inoculation of DV. In control mice PBS was injected in place of CY and 
the mortality pattern was studied. 
Effect of C Y on adoptive immunization by antiserum. Mice were given CY i.p. followed 5 h 
later by o'5 ml DV antiserum i.p., prepared in mice as described elsewhere (Chaturvedi 
et aL 1977). After 24 h the mice were challenged i.c. with DV. As controls, mice of one group 
(A) were given CY i.p. and normal mouse serum in place of antiserum, mice of control 
group B were given CY, antiserum and saline in place of virus and control group C received 
antiserum only. After this treatment control groups A and C were challenged i.c. with 
DV. The mortality pattern was recorded in each group (Table I). 
In a second experiment CY given i.p. was followed 5 h later by o'5 ml of DV antiserum 
i.p. After 24 h these mice were challenged i.c. with DV, and 72 h later the same mice were 
again given o'5 ml of DV antiserum i.p. Controls were included as in the first experiment 
and the mice were observed aily for 2I days. In both experiments virus titres in the brain 
of the two mice sacrificed aily were determined for I I days after infection. 
Effect of CY on adoptive immunization by cells. Spleen cells obtained 2 weeks after immu- 
nization of mice with 4 weekly i.p. doses of live DV were given i.v. to normal mice in doses 
ranging from I x io 8 to 4 x io ~ cells. After 24 h the mice were challenged i.c. with DV and 
48 h later i.p. with CY. As a control, normal mouse spleen cells were used in place of immune 
cells (Table 2). 
In a second set of experiments, mice were given DV i.c. followed by CY i.p. 24 h later, 
and immune spleen cells i.v. in varying doses (I x lO a to 4 x lO 8 cells) after a further 48 h. 
Control mice were given normal mouse spleen cells (Table 3). 
Effect of CY on antibody plaque forming cells. Mice were given 0"5 ml DV i.p. followed 
24 h later by CY i.p. Control mice were given DV i.p. only. The experiment was repeated in 
a group of mice given virus by the i.c. route. Five to 7 mice were sacrificed aily for I I days  
after infection. Spleens were collected aseptically and the cells were squeezed out with 
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Tab le  I .  Effect of CY on protection of mice by antiserum against DV challenge 
DV antiserum Normal  serum 
~,__  _ _ A  r- 
DV CY I st 2nd I st 2nd Saline 
i.c. i.p. dose dose dose dose i.p. Mortality1" Group * 
Expt. 1 
Test 
Control A 
Control  B 
Control C 
Expt. 2 
Test 
Control  A 
Control  B 
+ ~ + + . . . .  20/20 
+ + - - + - - 14/14 
- + . . . .  + o /15  
+ - + . . . .  o/12 
+ + + + -- -- -- 2/18 
+ + - -  - -  + + -- 0/[6 
- -  + . . . .  + 0 / I5  
* A single dose of  specific ant iserum was sufficient o protect mice against subsequent challenge to DV 
24 h later (Expt. I, control C) but the protection was abolished by administrat ion of CY (Expt. I, Test). The 
protection by ant iserum could be restored in such mice by a second dose of  specific antiserum given 72 h 
after the first dose (Expt. 2, Test). 
1" Numerator ,  number  dying; denominator,  total number  of  mice. 
~: + ,  given; - ,  not given. 
Table 2. Effect of CY on mice pre-treated intravenously with immune or normal 
Group 
Immune cells 
Normal  cells 
mouse spleen cells* 
No. of  spleen D.V. CY 
(i.v.) cells i.c. i.p. Mortal i tyt  
4 × io s +:~ + io/ Io 
2 × IO s + + 9/Io 
I X 10 8 + + 12/12  
4 x lO  8 + - 8/8 
4x  1o 8 + + 12/12 
2 × I0  8 + + 9/9 
I x I 0  8 + + I2 /12  
4 x io  s -+- - -  IO/ IO 
* Spleen cells, obtained 2 weeks after 4th weekly immuniz ing dose of  DV, were given i.v. to normal  mice 
which were challenged with DV i.c. 24 h later and CY i.p. 48 h later. As control, normal  mouse spleen cells 
were given. Cell transfer had no effect on outcome of the infection. 
t Numerator ,  number  dying; denominator,  total number  of  mice. 
+ ,  given; - ,  not given. 
forceps. The cells were washed in Hanks' basal salt solution and the viable nucleated cells 
were counted by the trypan blue dye exclusion test. The modified haemolytic plaque tech- 
nique of Jerne, Nordin & Henry (1963) was used for counting antibody forming cells 
(PFC). Coating of the sheep RBCs with the virus (dengue or Coxsackie B4) was done by the 
technique of Russell, McCahon & Beare 0 975) after treating RBCs with 5 x I o- 4 M-KIO4. The 
PFC assays were read after incubation of slides at 37 °C for 90 min in the presence of fresh 
guinea pig complement. The PFC were scored at x 3o magnification with a microscope. 
Only direct PFC were counted. From each mouse, multiple slides were prepared epending 
on the count of spleen cells. 
Effect of CY on active immunization. Mice were immunized with live DV prepared from 
20 % (w/v) mouse brain suspension. DV (0"5 ml) was given i.p. on o, 7 and 14 days (group A). 
In another group (B) of mice each injection of DV was followed by CY 24 h later (on 
days I, 8 and I5). Similarly, a suspension prepared from normal mouse brain was given 
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Table 3. Effect of reconstitution with immune or normal mouse spleen cells given 
D V and CY* 
No. of spleen 
Group DV i.c. CY i.p. cells (i.v.) Mortality'~ 
Immune cells + ~ + 4 x io s ]4/x4 
+ + 2 X I0 8 12/ I2  
+ + I x i o  8 8/8 
+ - 4x IO s I2/I2 
Normal cells + + 4 x io s Io/Io 
-4- + 2 × I0 s IO/ I0 
+ + I × l0  s I0 / I0  
+ - 4 × I08 I0 / IO 
* Mice given DV i.c. followed 24 h later by CY were reconstituted with immune or normal mouse spleen 
cells (as in Table z) 48 h later. Cell transfer had no effect on the outcome of the infection. 
t Numerator, number dying; denominator, total number of mice. 
+,  given; - ,  not given. 
Table 4- Effect of CY on response of actively immunized mice to challenge with 
homologous or heterologous virus* 
Immunizing 
virus CY on days Challenge virus 
Groups days o, 7, I4 i, 8, I5t on day 25 Mortality:~ 
A DV -- DV 2/I8 
B DV + DV I8/18 
C DV - Cox. B4 2/ I5  
D DV + Cox. B4 3/I4 
E NMB§  - DV IO/ I0 
F NMB + DV I2 / I2  
* Mice given three doses of DV i.p., each followed 24 h later by CY, were challenged with homologous 
(DV) or heterologous (Coxsackie B4) virus and mortality was recorded. CY abolished the protective ffect 
of active immunization against he homologous virus. 
t +,  drug given; - ,  drug not given. 
:~ Numerator, number dying; denominator, total number of mice. 
§ NMB = normal mice brain. 
with (group F) or without CY (group E) to another set of mice as control. On the 25th day, 
mice were challenged with about 2oo LDs0 DV i.c. One set of these mice with (group D) 
or without (group C) treatment with CY were challenged with the Ioo TCID~0 of Coxsackie 
B4 virus (Table 4)- In one set of experiments the mortality of mice was recorded after 
challenge while in another set 3 to 4 mice were sacrificed aily after challenge and PFC 
were determined in the spleen as described above. In group B mice, the PFC against DV, 
and in mice of group D, the PFC against Coxsackie B4 virus, were studied. As control, PFC 
against Coxsackie B4 virus were studied in the spleen of normal mice after challenge with 
the same virus. 
RESULTS 
Effect on i.c. inoculation of virus 
Fig. r shows the mortality in each group. All the mice given DV alone (control) died by 
the I2th day of virus inoculation while those given CY one day before, on the same day, or 
one day after the virus died after 5 to 6 days. This difference was statistically significant. In 
contrast CY did not significantly affect survival of mice when its administration was delayed 
by more than I day. 
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Fig. I. Effect of CY on DV infection of adult mice. All mice received ioo LDso i.c. of virus and CY 
at different periods before or after the virus. 11--11, I day before; (3--0,  same day; O--O, [ day 
after; x - -x ,  2days after; /~--A, 3days after; A--A, 4days after; El--v1, 5 days after; 
I1--II, 6 days after; 11 . . . .  O, control. Each group consisted of io to I5 mice. 
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Fig. 2. Virus titres in the brain of infected mice on different days after inoculation. Each point 
represents an average for two mice. t i - -O,  Normal mice given DV and O--©, mice given DV 
followed by CY 24 hours later. 
The average titres of the virus in the brains of two mice at different days are shown in 
Fig. 2. It was noted that the titre of the virus was markedly higher from the 3rd day on in 
mice given CY. The maximum difference in titre in the CY treated and untreated mice 
was 2"7 logs on the 5th and 6th days. 
No illness or mortality was noted in 2o mice given DV i.p. Similarly, no ill effects were 
seen in 30 mice given CY. 
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Fig. 3. Virus titres in the brain of infected mice on different days after inoculation. Each point 
represents an average for two mice. O- -O ,  Mice treated with antisera i.p. followed by[CY 5 h 
later and DV i.c. 24 h later; O- -O ,  mice treated with antisera i.p. followed by D.V.i.c. 24 h later 
and A__A, mice treated with antisera i.p. followed by CY 5 h later, DV i.c. 24 h later and antisera 
i.p. 72 h later. 
840 t l ! ! I I I I I I I 
760 
680 
"~ 600 
r -  
520 
X 
440 
r t  
d 360 
Z 
280 
200 
120 
4O 
I I I I I I I I t i i 
0 1 2 3 4 5 6 7 8 9 10 It 
Time (days) 
Fig. 4. Antibody plaque forming cells (PFC) in the spleen of infected mice on different days after 
inoculation. Each point represents the mean value from multiple slides from 5 to 7 mice with 
standard error of mean outlined. O- -O ,  Mice infected with DV i.c. ; ~- -A ,  mice infected by DV 
i.c. followed by CY 24 h later; Q- -O ,  mice infected with DV i.p. and A- -A ,  mice infected with 
DV i.p. followed by CY 24 h later. 
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Effect on adoptive immunization by antiserum 
In the first experiment, mice receiving DV antiserum were protected against i.c. challenge 
with virus (control group C) while normal mouse serum provided no protection (group A). 
The antiserum failed to protect mice when CY was also given as all the 2o mice died 
(Table I). In the second experiment where the second dose of antiserum was given 72 h 
later, 16 out of 18 mice survived the challenge with DV while controls behaved as in the 
first experiment (Table I). 
The titres of the virus in the brain of mice in different experiments have been shown in 
Fig. 3. It was noted that a small amount of virus was present in the brain between the 4th 
and 7th days and then disappeared in mice given virus and antiserum. In groups of mice 
also given CY the virus titres started increasing from the 3rd day but when two doses of 
antiserum were given a small amount of virus was detected for a few days. 
Effect of CY on adoptive immunization by cells 
The effect of CY on adoptive immunization by transfer of immune spleen cells has been 
summarized in Table z. Pre-treatment of mice with immune or normal spleen cells did not 
affect the outcome of infection, nor did reconstitution with cells influence the effect of CY 
on mice receiving DV by i.c. inoculation (Table 3). 
Effect on antibody forming cells 
The effect of CY on antiviral PFC in the spleen of mice given a single injection of dengue 
virus by the i.c. or i.p. routes is shown in Fig. 4. Mice given virus alone by either route 
showed an increase in PFC which reached a peak on the 7th day. In contrast, the PFC 
decreased in CY treated mice, reaching the lowest count on the 4th or 5th day. The count 
increased later but the mice given virus i.c. and CY had died by the 6th day. 
Effect on active immunization 
Out of I8 immunized mice only 2 died after challenge with DV. In contrast mice given 
DV followed by CY showed no protection to challenge by DV as all the I8 mice became 
sick and died. All the control mice given normal mouse brain suspension died on challenge 
with DV irrespective of CY treatment (Table 4). CY treatment did not affect he results of 
challenge with Coxsackie B4 virus. 
The immune response of the animals in this experiment was further investigated by 
studying PFC in the spleen (Fig. 5). Mice treated with three doses of DV, each followed by 
CY 24 h later (see group B, Table 4) showed negligible anti-DV PFC initially, on challenge 
with DV. The count gradually increased reaching 360 PFC/2 × Io 6 spleen cells on the 
I I th day. The response of similarly treated mice against a heterologous virus (Coxsackie B4) 
was studied to see whether the lowered PFC count was specifically for DV antigen. Results 
of this experiment (mice of group D, Table 4) showed that on challenge with Coxsackie B4 
virus, PFC against Coxsackie B4 virus increased to 53 o PFC/2 × IO 6 spleen cells on the 
7th day and then declined. The untreated normal control mice on challenge with Coxsackie 
B4 virus showed a similar curve except hat the number of PFC was much greater. Thus, 
treatment of mice with CY following an antigenic stimulus eliminates PFC against hat 
antigen specifically but has little effect on PFC reactive against an unrelated antigen. 
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Fig. 5. Antibody plaque forming cells (PFC) in the spleen of mice given three weekly doses of DV, 
each being followed by CY 24 h later. O- -Q ,  PFC against DV in mice challenged with DV i.p. 
on 25th day; A- -A ,  PFC against Coxsackie B4 virus in mice challenged with Coxsackie B4 
virus i.p. on 25th day; ©--©, PFC against Coxsackie B4 virus in normal mice given Coxsackie 
B4 virus i.p. Each point represents the mean value of multiple slides from 3 to 4 mice with standard 
error of the mean outlined. 
DISCUSSION 
In spite of our repeated attempts, we have seen that DV given i.p. fails to produce sickness 
in mice while the same virus strain produces sickness and death on i.c. inoculation. Failure 
to produce sickness in mice by the i.p. route could be due to various reasons; either the DV 
fails to multiply sufficiently in the peritoneal tissue or the brain tissue is spared due to the 
blood-brain barrier when the virus is injected by i.p. route. However, the numbers of splenic 
PFC were nearly the same in both the situations (Tandon & Chaturvedi, 1977; Fig. 4)- 
Therefore it appears that the extent of antigenaemia is also nearly the same in both situations. 
The results of our experiments also showed that the mean survival time (MST) of infected 
mice was reduced when CY was given at the same time as virus. Similar reductions in MST 
have been reported with Coxsackie B 3 virus (Rager-Zisman & Allison, ~973). In our exper- 
iments MST was found to be inversely related to the titre of virus in the brain tissues. 
Moreover, CY given i.p. was found to increase the virus titre of brain tissue in infected mice 
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(Fig. z). Therefore it appears that CY helps the virus to multiply. It could be due to lowering 
of host-resistance (immunosuppression) to the infectious agent. It is known that CY causes 
latent damage to DNA (Santos & Owens, I966). Therefore, it is possible that CY also 
affects the functional capacity of local mesenchymal tissue of the brain which in turn leads 
to rapid multiplication of the virus. Studies of histology and virus concentration i  different 
organs of mice also showed significant findings in CY treated mice. 
We had seen earlier that adoptive immunization of mice with DV antiserum protected 
them from subsequent i.c. challenge with DV (Chaturvedi et al. ~977). Therefore, antiserum 
does possess ome protective role against DV infection. Either the antiserum neutralizes the 
infectivity of the virus or the immune-complexes are removed by the local phagocytic cells. 
However, CY treatment abolished the protection provided by the single dose of the anti- 
serum (Table I). It could be due to its effect on local glial cells which has been discussed 
earlier. A second dose of antiserum could reverse the immunosuppressive effects of CY, 
probably by neutralizing the virus in antibody excess in the presence of defective clearing 
of immune-complexes from the local area (Fig. 3). Pre-treatment or reconstitution f mice 
with normal or immune splenic cells did not affect he morbidity or mortality of mice given 
DV i.c. followed by CY i.p. This also supports our findings that cell mediated immunity 
plays no protective role in DV infection of mice (Chaturvedi et al. I977). 
The reduction in splenic PFC against DV was very marked in our experiments where 
3 doses of DV were followed by CY treatment 24 h after each dose (Fig. 5). The results of 
this experiment could be explained on the basis of the effect of CY on rapidly proliferating 
cells. Therefore, the clonal proliferation and differentiation of antibody-forming cells 
(B lymphocytes) against DV might not have occurred, though the response to Coxsackie B4 
virus remained almost unaffected. The study of PFC gives a good indication of antigen- 
specific hyporesponsiveness. 
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